- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 5/08 - Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Patent holdings for IPC class A61P 5/08
Total number of patents in this class: 69
10-year publication summary
|
2
|
2
|
1
|
4
|
4
|
6
|
5
|
5
|
7
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer Intellectual Property GmbH | 2410 |
8 |
| Crinetics Pharmaceuticals, Inc. | 125 |
5 |
| Spruce Biosciences, Inc. | 38 |
5 |
| Antisense Therapeutics Ltd. | 27 |
3 |
| Endo Pharmaceuticals Solutions Inc. | 22 |
3 |
| The Regents of the University of California | 20556 |
2 |
| Bayer Schering Pharma AG | 347 |
2 |
| Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | 175 |
2 |
| Edix SA | 10 |
2 |
| Shanghai Scizeng Medical Technology Co., Ltd. | 11 |
2 |
| Amryt Endo, Inc. | 5 |
2 |
| Novartis AG | 10345 |
1 |
| Mars, Incorporated | 2896 |
1 |
| Aeterna Zentaris GmbH | 41 |
1 |
| Beijing Neurosurgical Institute | 33 |
1 |
| Biotropics Malaysia Bhd | 21 |
1 |
| Dicerna Pharmaceuticals, Inc. | 188 |
1 |
| Emory University | 1702 |
1 |
| Forschungsverbund Berlin e.V. | 193 |
1 |
| The Government of The United States of America AS represented by The Secretary of The Department of Health and Human Services | 152 |
1 |
| Other owners | 24 |